Early Signs of a Historic Breakthrough in the Treatment of Alzheimer’s Disease? (BBC News / Nature)

Summary

Early results, based on small numbers of patients in a Phase I trial, indicate unprecedented progress in the development of a pharmacological treatment of Alzheimer’s Disease. The drug Aducanumab appears to combat (and reverse) the build-up of amyloid protein in the brain, and shows signs of being able to preserve memory and thinking skills in patients.

Researchers are cautiously optimistic. Phase III trials are underway.

Full Text Link

Reference

Parkinson, C. (2016). Alzheimer’s drug study gives ‘tantalising’ results. London: BBC Health News, August 31st 2016.

This relates to:

Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access; it may be available to view freely online for a limited period).

Reference

Sevigny, J. Chiao, P. [and] Bussière, T. [et al] (2016). The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature. Vol.537, pp.50–56. August 31st 2016.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Models of Dementia Care, Pharmacological Treatments, Quick Insights, Scotland, UK, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s